Neurology

COVID-19

Questions discussed in this category

How do you approach the timing of COVID-19 vaccination for patients with multiple sclerosis on B-cell depleting therapies?

3 Answers available

Papers discussed in this category

Neurology, 2020 Jul 29

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.

Cells, 2018 Dec 28

Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.

Related Topics in Neurology